HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qianqian Ma Selected Research

verticine

9/2022Synergistic anti-inflammatory effects of peimine, peiminine, and forsythoside a combination on LPS-induced acute lung injury by inhibition of the IL-17-NF-κB/MAPK pathway activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qianqian Ma Research Topics

Disease

6Neoplasms (Cancer)
01/2022 - 09/2016
5Non-alcoholic Fatty Liver Disease
05/2022 - 01/2020
5Inflammation (Inflammations)
02/2022 - 11/2019
4Breast Neoplasms (Breast Cancer)
04/2019 - 01/2015
3Acute Lung Injury
10/2022 - 03/2022
3Fibrosis (Cirrhosis)
12/2021 - 01/2020
2Fatty Liver
01/2022 - 01/2021
2Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 12/2021
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 01/2019
2Alzheimer Disease (Alzheimer's Disease)
01/2020 - 02/2014
2AIDS-Related Complex (ARC)
01/2019 - 01/2019
1Lung Injury
03/2022
1Bronchitis
03/2022
1Metabolic Diseases (Metabolic Disease)
01/2022
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022
1Hyperlipidemias (Hyperlipidemia)
01/2022
1Cardiomegaly (Heart Hypertrophy)
01/2022
1Wounds and Injuries (Trauma)
01/2022
1Chronic Kidney Failure (Chronic Renal Failure)
01/2022
1IGA Glomerulonephritis (IGA Nephropathy)
01/2022
1Kidney Diseases (Kidney Disease)
01/2022
1Glioblastoma (Glioblastoma Multiforme)
01/2022
1Dyslipidemias (Dyslipidemia)
01/2022
1Lupus Nephritis
01/2022
1Liver Cirrhosis (Hepatic Cirrhosis)
12/2021
1Alcoholic Fatty Liver
09/2021
1Parkinson Disease (Parkinson's Disease)
06/2021
1Neurodegenerative Diseases (Neurodegenerative Disease)
05/2021
1Type 2 Diabetes Mellitus (MODY)
01/2021
1Esophageal Neoplasms (Esophageal Cancer)
01/2021
1Insulin Resistance
01/2021
1Obesity
01/2021
1Overweight
01/2021

Drug/Important Bio-Agent (IBA)

7LipidsIBA
05/2022 - 01/2016
7Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2015
4Therapeutic UsesIBA
03/2022 - 01/2017
3CytokinesIBA
09/2022 - 09/2021
3Triglycerides (Triacylglycerol)IBA
05/2022 - 01/2016
3Pharmaceutical PreparationsIBA
05/2021 - 01/2019
3Morphine (MS Contin)FDA LinkGeneric
01/2019 - 12/2017
2Ethanol (Ethyl Alcohol)IBA
10/2022 - 09/2016
2Proteins (Proteins, Gene)FDA Link
09/2022 - 05/2022
2LDL CholesterolIBA
05/2022 - 01/2020
2CholesterolIBA
05/2022 - 01/2021
2pteryxinIBA
03/2022 - 02/2022
2Messenger RNA (mRNA)IBA
01/2022 - 01/2020
2EnzymesIBA
01/2022 - 05/2021
2Biological ProductsIBA
11/2021 - 01/2021
2Circular RNAIBA
06/2021 - 01/2020
2Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2016
2MicroRNAs (MicroRNA)IBA
01/2020 - 01/2020
2PolymersIBA
04/2019 - 01/2019
2Ficusin (Psoralen)IBA
04/2019 - 01/2019
1verticineIBA
09/2022
1forsythiasideIBA
09/2022
1peiminineIBA
09/2022
1Interleukin-17 (Interleukin 17)IBA
09/2022
1Angiopoietin-Like Protein 3IBA
05/2022
1Single-Domain AntibodiesIBA
05/2022
1InflammasomesIBA
03/2022
1AntipyreticsIBA
03/2022
1Antitussive Agents (Antitussives)FDA Link
03/2022
1Expectorants (Mucolytics)IBA
03/2022
16-methyladenineIBA
01/2022
1ChemokinesIBA
01/2022
1N-methyladenosineIBA
01/2022
1Complement System Proteins (Complement)IBA
01/2022
1linaloolIBA
01/2022
1Drug CombinationsIBA
01/2022
1Transaminases (Aminotransferases)IBA
01/2022
1Interleukin-22 (IL-22)IBA
01/2022
1EucalyptolIBA
01/2022
1Isoproterenol (Isoprenaline)FDA LinkGeneric
01/2022
1caryophylleneIBA
01/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2021
1ApolipoproteinsIBA
12/2021
1limoninIBA
11/2021
1Carbon Tetrachloride (Tetrachloromethane)IBA
09/2021
1CollagenIBA
09/2021
1Caspase 1 (ICE Protease)IBA
09/2021
1corosolic acidIBA
09/2021
1RNA (Ribonucleic Acid)IBA
06/2021
1TransferasesIBA
05/2021
1Neuroprotective AgentsIBA
05/2021
1FlavonolsIBA
05/2021
1HDL-triglycerideIBA
01/2021
1oxidized low density lipoproteinIBA
01/2021
1Apolipoproteins B (ApoB)IBA
01/2021
1Apolipoproteins E (ApoE)IBA
01/2021
1Nonesterified Fatty Acids (NEFA)IBA
01/2021
1GlycogenIBA
01/2021
1Insulin (Novolin)FDA Link
01/2021
1Lipoproteins (Lipoprotein)IBA
01/2021
1Small Interfering RNA (siRNA)IBA
01/2021
1Uric Acid (Urate)IBA
01/2020
1Blood Glucose (Blood Sugar)IBA
01/2020

Therapy/Procedure

5Therapeutics
05/2022 - 06/2018
3Drug Therapy (Chemotherapy)
01/2019 - 01/2017
1Combination Drug Therapy (Combination Chemotherapy)
01/2022
1Radiotherapy
01/2021